827 related articles for article (PubMed ID: 11748971)
1. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of DNA content in epithelial ovarian cancer.
Gajewski WH; Fuller AF; Pastel-Ley C; Flotte TJ; Bell DA
Gynecol Oncol; 1994 Apr; 53(1):5-12. PubMed ID: 8175021
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of DNA ploidy and S-phase fraction in endometrial cancer stage I and II: a prospective 5-year survival study.
Friberg LG; Norén H; Delle U
Gynecol Oncol; 1994 Apr; 53(1):64-9. PubMed ID: 8175025
[TBL] [Abstract][Full Text] [Related]
4. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
Meyer JS; Gersell DJ; Yim S
Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of nuclear DNA quantification and cyclin A expression in epithelial ovarian carcinoma.
Yoon BS; Kim YT; Kim S; Lee CS; Kim JW; Kim JH; Kim SW; Cho NH
Eur J Obstet Gynecol Reprod Biol; 2008 Jan; 136(1):110-5. PubMed ID: 17157431
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of DNA content and S-phase fraction in epithelial ovarian carcinomas analyzed by image cytometry.
Reles AE; Gee C; Schellschmidt I; Schmider A; Unger M; Friedmann W; Lichtenegger W; Press MF
Gynecol Oncol; 1998 Oct; 71(1):3-13. PubMed ID: 9784312
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric DNA analysis of breast cancer by two colour method using cytokeratin labeling for identification of tumour cells.
Kimmig R; Spelsberg H; Kapsner T; Untch M; Hepp H
Anal Cell Pathol; 1994 Oct; 7(3):205-15. PubMed ID: 7531483
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of DNA ploidy and S-phase fraction in stage I endometrial carcinoma.
Pfisterer J; Kommoss F; Sauerbrei W; Rendl I; Kiechle M; Kleine W; Pfleiderer A
Gynecol Oncol; 1995 Aug; 58(2):149-56. PubMed ID: 7622098
[TBL] [Abstract][Full Text] [Related]
9. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry.
Zarbo RJ; Nakhleh RE; Brown RD; Kubus JJ; Ma CK; Mackowiak P
Cancer; 1997 Jun; 79(11):2073-86. PubMed ID: 9179053
[TBL] [Abstract][Full Text] [Related]
11. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of DNA flow cytometry in stomach cancer: a 5-year prospective study.
Lee KH; Lee JS; Lee JH; Kim SW; Suh C; Kim WK; Kim SH; Min YI; Kim BS; Park KC; Lee MS; Sun HS
Br J Cancer; 1999 Apr; 79(11-12):1727-35. PubMed ID: 10206284
[TBL] [Abstract][Full Text] [Related]
13. Clinical value of morphometric and DNA flow cytometric variables as independent predictors of survival in epithelial ovarian carcinoma: a 5-year follow-up study.
Veerman MM; van der Wurff AA; van de Water M; Kruitwagen RF; Feijen HW; Vos MC
Int J Gynecol Pathol; 2009 Sep; 28(5):432-41. PubMed ID: 19696612
[TBL] [Abstract][Full Text] [Related]
14. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
[TBL] [Abstract][Full Text] [Related]
16. Alteration of DNA ploidy status and cell proliferation induced by preoperative radiotherapy is a prognostic factor in rectal cancer.
Lammering G; Taher MM; Gruenagel HH; Borchard F; Porschen R
Clin Cancer Res; 2000 Aug; 6(8):3215-21. PubMed ID: 10955806
[TBL] [Abstract][Full Text] [Related]
17. Influence of cellular DNA content on survival in ovarian carcinoma.
Klemi PJ; Joensuu H; Mäenpää J; Kiilholma P
Obstet Gynecol; 1989 Aug; 74(2):200-4. PubMed ID: 2748056
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic variables, operative characteristics, and DNA ploidy in predicting outcome in ovarian epithelial carcinoma.
Rice LW; Mark SD; Berkowitz RS; Goff BA; Lage JM
Obstet Gynecol; 1995 Sep; 86(3):379-85. PubMed ID: 7651646
[TBL] [Abstract][Full Text] [Related]
19. DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas.
Dolan JR; McCall AR; Gooneratne S; Walter S; Lansky DM
Gynecol Oncol; 1993 Feb; 48(2):232-5. PubMed ID: 8428696
[TBL] [Abstract][Full Text] [Related]
20. Lack of prognostic significance of ploidy and S-phase measurements in advanced ovarian cancer.
Coley HM; Sargent JM; Titley J; Taylor CG
Anticancer Res; 1999; 19(3A):2111-6. PubMed ID: 10470157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
